Special surveillance drive by CDSCO on mfg sites report 2.3% samples only substandard quality

Posted on Updated on

A special drive of surveillance on manufacturing sites by the Central Drugs Standard Control Organisation (CDSCO) spread across the country has found that only little above two per cent of drug samples were of not-standard quality while no spurious drug could be traced.

The results also showed that Jammu region emerged as the top hub for substandard drugs, going by the results of tests of samples collected through special drive from manufacturing sites and also the joint raids by the CDSCO and the state authorities in hospitals and chemist shops.

As part of the surveillance of drug manufactured in the country, the CDSCO collected as many as 1710 drug samples from the manufacturing sites located at various manufacturing hub/clusters/locations falling under jurisdiction of CDSCO zonal and sub-zonal offices under the special drive launched in December 2012. Out of the total samples, 1123 were tested at its drug testing laboratories and only 26 were found to be of not-standard quality.

The North Zone collected 229 samples and got 219 of them tested, and seven were found to be of not-standard quality, while the South Zone reported no cases of substandard quality after collecting 278 samples and testing 112 of them. West Zone also reported seven cases of not-standard quality, out of the total 161 samples went for tests.

Under the Bengaluru sub-zonal office, 309 samples were collected and 296 were tested, resulting into only two cases of substandard drugs. However, out of the 30 samples tested by Jammu office, four turned out to be substandard. The drive did not report any case of spurious drugs.

“Concerned State Drug Controllers were informed to stop the further distribution of drugs in the market and to take action against manufacturers under Drugs & Cosmetics Act 1940,” the CDSCO said about the steps taken following the finding of substandard drugs.

The agency also said joint surprise checks were conducted with State Drugs Controllers to check the quality of drugs on monthly basis. Under this, samples were drawn from government hospitals, retail and wholesale dealers having different pharmacological categories from the month April 2013.

As part of these joint checks, 706 samples were collected and 306 were tested. Out of them, 35 were found to be of substandard. During the raids in April, in Jammu and Kashmir, the officials seized 156 samples and got them tested. Out of them, 27 were found of substandard quality. Following the checks conducted in Himachal Pradesh, 121 samples were taken and 97 of them were tested. Out this, seven turned out to be of not-standard quality.

Checks were also held in Madhya Pradesh (June), Assam and Meghalaya (July), Bihar (August), Uttar Pradesh (September), Uttarakhand (October), Odisha (November) and Rajasthan (December) by the teams from the CDSCO and the State authorities.

Source: PharmaBiz


Let us know what you think!

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Google+ photo

You are commenting using your Google+ account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )


Connecting to %s